Scientists with a quick start and phases executed in parallel, such as scaling up manufacturing before successful confirmation of the outcomes, the scientists believe the process can be fast-tracked, but with high financial risks WASHINGTON : Scientists have proposed a new truncated process for developing vaccines quickly during a pandemic, with a fast start and many steps executed in parallel before confirming a successful outcome of another step, an approach they claim can help stop the COVID-19 crisis.
According to the researchers from the Coalition for Epidemic Preparedness Innovation (CEPI), vaccine development is a lengthy, expensive process with high rates of attrition, typically taking multiple candidates, and many years to produce